 |
Articles: Chemotherapy/Oncology |
Prior Articles
Is zoledronic acid an anticancer drug
Expert Opinion in Pharmacotherapy, 10/05/09
A review on the treatment of relapsed/metastatic head and neck cancer
Expert Opinion in Pharmacotherapy, 10/05/09 Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth
Expert Opinion on Investigational Drugs, 10/02/09 Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based
Expert Opinion on Investigational Drugs, 10/02/09
Exclusive Author Commentary A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology, 10/01/09
Exclusive Author Commentary A Comparison of Phase II Study Strategies
Clinical Cancer Research, 10/01/09 Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
Clinical Cancer Research, 10/01/09 Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03
British Journal of Cancer, 10/01/09 Actual status of adjuvant chemotherapy for non-small-cell lung cancer at one Japanese cancer center: the need for increased cooperation between medical oncologists and surgeons
Medical Oncology, 10/01/09 Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapy
The Lancet Oncology, 10/01/09 Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer
Expert Opinion on Investigational Drugs, 09/30/09 Darinaparsin: a novel organic arsenical with promising anticancer activity
Expert Opinion on Investigational Drugs, 09/30/09 Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination
Annals of Surgical Oncology, 09/30/09 Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients
Cancer Chemotherapy and Pharmacology, 09/30/09 Pegylated liposomal doxorubicin combined with carboplatin: A rational treatment choice for advanced ovarian cancer
Critical Reviews in Oncology/Hematology, 09/30/09 Investigational drugs targeting FLT3 for leukemia
Expert Opinion on Investigational Drugs, 09/29/09 Locally advanced rectal cancer: from molecular profiling to clinical practice
Expert Opinion in Pharmacotherapy, 09/29/09 A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
Clinical Cancer Research, 09/29/09 Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
Clinical Cancer Research, 09/29/09 Effectively discussing complementary and alternative medicine in a conventional oncology setting: Communication recommendations for clinicians
Patient Education and Counselling, 09/29/09
Revew Article
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
